Αρχειοθήκη ιστολογίου

Δευτέρα 11 Σεπτεμβρίου 2017

Nivolumab vs ipilimumab for high risk melanoma patients

Dr Weber presents in a press conferene at the ESMO 2017 Congress in Madrid the data from a large, randomised, phase III trial in which patients with stage IIIb/c/IV melanoma, identified as high risk individuals, were treated with either nivolumab or...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eYyg07
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader